Terms: = Prostate cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Diagnosis
31 results:
1. MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer.
Zeng Z; He W; Jiang Y; Jiang H; Cheng X; Deng W; Zhou X; Zhang C; Wang G
BMC Cancer; 2022 Nov; 22(1):1162. PubMed ID: 36357836
[TBL] [Abstract] [Full Text] [Related]
2. Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer.
Hakozaki Y; Yamada Y; Kawai T; Nakamura M; Takeshima Y; Iwaki T; Teshima T; Kinoshita Y; Fujii Y; Akiyama Y; Sato Y; Yamada D; Suzuki M; Kashiwagi-Hakozaki M; Ushiku T; Kume H
Sci Rep; 2022 Sep; 12(1):16202. PubMed ID: 36171391
[TBL] [Abstract] [Full Text] [Related]
3. Metastatic SMARCB1 Deficient Skin Carcinoma With Neuroendocrine Differentiation in the Parotid Glands Clinically Mimicking Primary Salivary Gland Malignancy: Unusual Case With Diagnostic Pitfalls.
Fang F; Zhang QI; Pinto-Cuberos JM; Lai J
Anticancer Res; 2022 Aug; 42(8):3971-3974. PubMed ID: 35896245
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer dormancy and recurrence.
Cackowski FC; Heath EI
Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433
[TBL] [Abstract] [Full Text] [Related]
5. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract] [Full Text] [Related]
6. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
Qureshi Z; Ahmad M; Yang WX; Tan FQ
Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
[TBL] [Abstract] [Full Text] [Related]
7. Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
Piao XM; Hwang B; Jeong P; Byun YJ; Kang HW; Seo SP; Kim WT; Lee JY; Ha YS; Lee YS; Kim IY; Choi YH; Cha EJ; Moon SK; Yun SJ; Kim WJ
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982770
[TBL] [Abstract] [Full Text] [Related]
8. EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.
Fu C; Zhang Q; Wang A; Yang S; Jiang Y; Bai L; Wei Q
Mol Oncol; 2021 May; 15(5):1543-1565. PubMed ID: 33605506
[TBL] [Abstract] [Full Text] [Related]
9. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2.
Li XL; Li SZ; Wu CX; Xing XH
Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
[TBL] [Abstract] [Full Text] [Related]
10. miR-203 inhibits cell proliferation and erk pathway in prostate cancer by targeting IRS-1.
Meng Y; Hu X; Li S; Zeng X; Qiu L; Wei M; Wang Z; Han J
BMC Cancer; 2020 Oct; 20(1):1028. PubMed ID: 33109107
[TBL] [Abstract] [Full Text] [Related]
11. Mxi-2 Dependent Regulation of p53 in prostate cancer.
KÖditz B; Fries JWU; GÖbel H; Paffenholz P; Richter K; Heidenreich A; VON Brandenstein M
Anticancer Res; 2020 Oct; 40(10):5539-5544. PubMed ID: 32988877
[TBL] [Abstract] [Full Text] [Related]
12. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma.
Bakhshwin A; Berry RS; Cox RM; Li R; Reynolds JP; Rubin BP; McKenney JK
Pathology; 2020 Oct; 52(6):643-648. PubMed ID: 32758370
[TBL] [Abstract] [Full Text] [Related]
13. Gene set based systematic analysis of prostate cancer and its subtypes.
Ye S; Wang H; He K; Shen H; Peng M; Nian Y; Cui R; Yi L
Future Oncol; 2020 Jan; 16(2):4381-4393. PubMed ID: 31814446
[No Abstract] [Full Text] [Related]
14. Primary Extracranial Meningioma of Mastoid in a Patient With History of Skin Squamous Cell Carcinoma, Lung Adenocarcinoma and Prostatic Carcinoma.
Hu M; Tang Y; Long G; Zhang D; Kresak JL; Lai J
Anticancer Res; 2019 Jun; 39(6):3197-3201. PubMed ID: 31177167
[TBL] [Abstract] [Full Text] [Related]
15. Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
Gao Y; Deng K; Liu X; Dai M; Chen X; Chen J; Chen J; Huang Y; Dai S; Chen J
J Cell Biochem; 2019 Apr; 120(4):6370-6383. PubMed ID: 30390344
[TBL] [Abstract] [Full Text] [Related]
16. Upregulated circular RNA circ-102004 that promotes cell proliferation in prostate cancer.
Si-Tu J; Cai Y; Feng T; Yang D; Yuan S; Yang X; He S; Li Z; Wang Y; Tang Y; Ye C; Li Z
Int J Biol Macromol; 2019 Feb; 122():1235-1243. PubMed ID: 30219508
[TBL] [Abstract] [Full Text] [Related]
17. Quantification of cancer risk in glomerulonephritis.
Heaf JG; Hansen A; Laier GH
BMC Nephrol; 2018 Feb; 19(1):27. PubMed ID: 29394927
[TBL] [Abstract] [Full Text] [Related]
18. Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer.
Khakshour S; Labrecque MP; Esmaeilsabzali H; Lee FJS; Cox ME; Park EJ; Beischlag TV
Sci Rep; 2017 Aug; 7(1):7833. PubMed ID: 28798482
[TBL] [Abstract] [Full Text] [Related]
19. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract] [Full Text] [Related]
20. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
[TBL] [Abstract] [Full Text] [Related]
[Next]
